AU201813182S - Plantar Fasciitus Strengthening Pad - Google Patents

Plantar Fasciitus Strengthening Pad

Info

Publication number
AU201813182S
AU201813182S AU201813182F AU201813182F AU201813182S AU 201813182 S AU201813182 S AU 201813182S AU 201813182 F AU201813182 F AU 201813182F AU 201813182 F AU201813182 F AU 201813182F AU 201813182 S AU201813182 S AU 201813182S
Authority
AU
Australia
Prior art keywords
fasciitus
plantar
strengthening pad
pad
strengthening
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU201813182F
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fasciitis Fighter Pty Ltd
Original Assignee
Fasciitis Fighter Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fasciitis Fighter Pty Ltd filed Critical Fasciitis Fighter Pty Ltd
Priority to AU201813182F priority Critical patent/AU201813182S/en
Publication of AU201813182S publication Critical patent/AU201813182S/en
Active legal-status Critical Current

Links

Abstract

New Distinct purpose made Pad to aid in the treatment relief and support of Plantar Fasciitus
AU201813182F 2018-05-28 2018-05-28 Plantar Fasciitus Strengthening Pad Active AU201813182S (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU201813182F AU201813182S (en) 2018-05-28 2018-05-28 Plantar Fasciitus Strengthening Pad

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU201813182F AU201813182S (en) 2018-05-28 2018-05-28 Plantar Fasciitus Strengthening Pad

Publications (1)

Publication Number Publication Date
AU201813182S true AU201813182S (en) 2018-06-28

Family

ID=71572830

Family Applications (1)

Application Number Title Priority Date Filing Date
AU201813182F Active AU201813182S (en) 2018-05-28 2018-05-28 Plantar Fasciitus Strengthening Pad

Country Status (1)

Country Link
AU (1) AU201813182S (en)

Similar Documents

Publication Publication Date Title
PH12019501575A1 (en) ISOFORM-SPECIFIC, CONTEXT-PERMISSIVE TGFá1 INHIBITORS AND USE THEREOF
AU201817351S (en) Massage roller
TWD187898S (en) Massage apparatus
MX2020012823A (en) Substituted alkoxypyridinyl indolsulfonamides.
TWD192896S (en) Massager
MX2020001406A (en) Mavacamten for use in the treatment of hypertrophic cardiomyopathy.
EA201790737A1 (en) COMBINED THERAPY
AU201810494S (en) Ankle support
CL2018000927A1 (en) Combined therapy for the treatment of malignant neoplasms
GEP20217317B (en) Combination therapy for the treatment of cancer
MX2022007994A (en) Arylcyclohexylamine derivatives and their use in the treatment of psychiatric disorders.
MX2023010501A (en) Dantrolene prodrugs and methods of their use.
MX2020001727A (en) Combination therapy.
MX2019008233A (en) Targeted doxorubicin-gold nanoconjugates for tumor therapy.
MX2016014913A (en) Device and formulation for topical treatment of pain affecting the vulvar area of the female human genital organ.
AU201717316S (en) Skin treatment article
ZA202104786B (en) Deutetrabenazine for the treatment of dyskinesia in cerebral palsy
ZA202006891B (en) Selection and use of melatonin supporting bacteria to reduce infantile colic
TW201612313A (en) Uses of ligustilide
MX2022005250A (en) Therapeutic combinations of acalabrutinib and capivasertib to treat b-cell malignancies.
AU201813182S (en) Plantar Fasciitus Strengthening Pad
MX2022002699A (en) Lurbinectedin in the treatment of malignant mesothelioma.
WO2018183494A8 (en) Cd19-targeting antibody-drug conjugates
MX2020002092A (en) Methods and devices for use in treatment of plantar fasciitis and fat grafting.
TW201612314A (en) Uses of ligustilide for enhancing the efficacy of stem cells on treating autoimmune diseases, cardiovascular diseases, and/or hematological diseases